Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board
December 14, 2024 16:54 ET
|
Kellner Group
Vote “FOR” All Four Kellner Group Nominees Today on Gold Card for Urgently Needed Change Kellner Group Owns 5.04% of Outstanding Shares and is Fully Aligned with Stockholders NEW YORK, Dec. 14,...
UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
December 13, 2024 15:48 ET
|
Kellner Group
Incumbent Board has Destroyed Stockholder Value and Imperiled AIM’s Future through Breaches of Fiduciary Duty and Bad Faith Actions Stock Price has Declined by More than 99%, Clinical Strategy has...
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
December 13, 2024 12:11 ET
|
Kellner Group
Incumbent Board has Destroyed Stockholder Value and Imperiled AIM’s Future through Breaches of Fiduciary Duty and Bad Faith Actions Stock Price has Declined by More than 99%, Clinical Strategy has...
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
December 13, 2024 09:46 ET
|
Kellner Group
Vote “FOR” All Four Kellner Group Nominees for Urgently Needed Change Incumbent Board has Destroyed Stockholder Value and Imperiled AIM’s Future through Breaches of Fiduciary Duty and Bad...
Kellner Group Announces Support from Another Former AIM Senior Executive
December 12, 2024 08:16 ET
|
Kellner Group
Follows Announcement Earlier this Week that Ampligen Co-Founder and Former AIM CEO Agreed to Join Scientific Advisory Board if Kellner Group Nominees Are Elected Kellner Group Reiterates Plan to...
AIM’s Clinical Strategy Under Incumbent Board Has Totally Failed
December 11, 2024 07:30 ET
|
Kellner Group
Incumbent Board’s Claims of Progress Are Not Credible or Supported by DataAIM Maintains Relationship with CRO Co-Founded by a Convicted Felon Who Deceived Investors about the Timeline and Status of...
Ampligen Co-Inventor and Former CEO Agrees to Join AIM Scientific Advisory Board if Kellner Group Nominees Are Elected
December 10, 2024 07:30 ET
|
Kellner Group
Kellner Group Owns 5.04% of Outstanding Shares and is Fully Aligned with Stockholders Kellner Group Urges Stockholders of AIM Immunotech to Vote the Gold Card NEW YORK, Dec. 10, 2024 (GLOBE...
Kellner Group Urges Stockholders of AIM Immunotech to Vote the Gold Card
December 06, 2024 08:34 ET
|
Kellner Group
ISS Notes Need for Significant Board Change at AIM Due to Clinical Failure and Lack of Transparency According to ISS – “There is no question that for shareholders to have any hope of not losing 100...
Kellner Group Urges Stockholders of AIM Immunotech to Vote the Gold Card
December 02, 2024 07:30 ET
|
Kellner Group
Kellner Group Has Financial Resources AIM Needs Kellner Group Owns 5.04% of Outstanding Shares and is Fully Aligned with Stockholders AIM Cash Conservation Plan is Too Little Too Late, Exposes...
Kellner Group Urges Stockholders of AIM Immunotech to Vote Enclosed Gold Card
November 26, 2024 07:00 ET
|
Kellner Group
AIM Stock Price Has Declined 99+% and Incumbent AIM Board Is Misleading Stockholders Kellner Group Owns 5.04% of Outstanding Shares and is Fully Aligned with Stockholders NEW YORK, Nov. 26, 2024 ...